T1	Participants 303 446	21 obese subjects imperfectly controlled by 20 mg of glyburide daily in a double masked, placebo-controlled, parallel design, 16-week protocol.
T2	Participants 600 757	Eleven subjects using insulin plus 10 mg glyburide before breakfast had lower mean fasting glucose at 10-16 weeks than 10 subjects using insulin with placebo
T3	Participants 1405 1439	obese persons with type 2 diabetes
